Please login to the form below

Not currently logged in
Email:
Password:

Penn launches US operation

UK-based Penn Pharmaceutical Services has launched a company in North America, in the next phase of its growth in the region after a recent GBP 67m (USD 139.5m) management buyout.

UK-based Penn Pharmaceutical Services has launched a company in North America, in the next phase of its growth in the region after a recent GBP 67m (USD 139.5m) management buyout.

Penn, which provides integrated pharmaceutical outsourcing services, has set up Penn Pharmaceutical Services US in Philadelphia. The company has hired Paul Wituschek as director of business development to head up the new business arm.

Penn employs more than 200 people and operates from a base in Wales. It provides a variety of technical services to the pharmaceutical industry through three core divisions.

Wituschek has over 20 years' experience in executive level sales, marketing and management experience in private sector business. He has also worked in pharmaceutical, biotechnology, healthcare, insurance and publishing industries, managing teams globally throughout North America, the UK and the EU.

Most recently, Wituschek was global sales director for the Pharma Solutions Business Unit of US-based Wolters Kluwer Health, where he had profit and loss responsibility for the Global Business Intelligence portfolio and led his teams to record sales and revenue growth.

Penn Pharmaceutical's CEO, Peter George, said: "Development of our North American office is critical to maintain our planned growth rate of over 20 per cent and Paul has all of the assets required to drive the business forward and increase our presence there. As a member of the executive management team, Paul will ensure that future developments take account of the North American market needs."

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics